1 company and 4 research reports found for "AVEO Pharmaceuticals"
- AVEO Pharmaceuticals
AVEO Pharmaceuticals is a US biotech company focused on oncology. Tivozanib (triple VEGF inhibitor):...
No sector reports have been found.
AVEO PharmaceuticalsPharmaceutical & healthcare | 15/02/2013
Aveo has revealed final overall survival (OS) Phase III data for tivozanib in renal cell carcinoma (RCC), which shows a median OS of 28.8 months for t...
AVEO PharmaceuticalsPharmaceutical & healthcare | 10/08/2012
FDA ‘concerns’ on overall survival trend data from the TIVO-1 trial of Aveo’s tivozanib in renal cell carcinoma (RCC) is certainly p...
AVEO PharmaceuticalsPharmaceutical & healthcare | 08/05/2012
Aveo’s stock is some 30% off its January levels as investor doubts have crept in during the run-up to an important Phase III presentation at ASC...